Domperidone for cancer patients with severe stomach or gut symptoms
Part of Cancer, Digestive system clinical trials.
This program offers domperidone, a medicine that helps the stomach and gut move food along, to cancer patients whose nausea, vomiting, heartburn, or severe constipation has not improved with standard treatments. It aims to relieve these symptoms and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cancer and have symptoms like persistent heartburn, nausea, vomiting, severe indigestion, or severe constipation that have not responded to usual treatments.
- You have had a physical exam and possibly tests like an endoscopy or gastric emptying study to rule out other causes.
- You do not have a history of serious heart rhythm problems (like ventricular tachycardia or Torsade de Pointes) and your heart rhythm test (ECG) shows no significant abnormalities.
- You are not pregnant or breastfeeding, and you do not have a known allergy to domperidone.
- You are willing to sign a consent form that explains possible side effects, including hormonal changes, movement issues, breast changes, and heart rhythm changes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether domperidone can help people ages 12–21 with symptoms from stomach not moving well when usual treatments haven’t worked. It’s designed for cases where other causes have been ruled out and patients are monitored for possible heart and hormone side effects.
This trial tests whether a medicine called domperidone, which helps the stomach empty faster, can improve blood sugar control in people with type 1 diabetes who have slow stomach emptying. It may help by reducing blood sugar swings and early after-meal lows.
This trial tests a procedure called G-POEM that may help with severe gastroparesis, where the stomach is slow to empty. It aims to improve blood sugar control and stomach symptoms for people with diabetes.
This trial tests a new way to program an implanted device (Enterra®) to better treat severe nausea and vomiting caused by gastroparesis. If you have frequent nausea and vomiting despite other treatments, this study might help find a better setting for your device.
This trial tests whether ondansetron can improve stomach “sensorimotor” problems—how the gut senses food and moves it—especially in people with diabetes and troubling indigestion. It may help reduce symptoms like early fullness, nausea, and discomfort after eating.
This study tests two medications (fosrolapitant and palonosetron) to prevent severe nausea and vomiting in patients with esophageal or lung cancer who are receiving chemotherapy combined with immunotherapy. If the medications work well, they could help patients feel better during treatment and complete their cancer care more comfortably.
Hear when a new Oncology Patients With Gastroparesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.